# Effect of Inhalatory Sedation in Subarachnoid Hemorrhage

> **NCT05213832** · PHASE2 · COMPLETED · sponsor: **A.O.U. Città della Salute e della Scienza** · enrollment: 11 (actual)

## Conditions studied

- Subarachnoid Hemorrhage
- Aneurysmal Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Isoflurane Inhal Soln

## Key facts

- **NCT ID:** NCT05213832
- **Lead sponsor:** A.O.U. Città della Salute e della Scienza
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-26
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05213832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05213832, "Effect of Inhalatory Sedation in Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05213832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
